Literature DB >> 18818555

Nitazoxanide treatment of Cryptosporidium parvum in human immunodeficiency virus-infected children.

Edmund V Capparelli, Salma S Syed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18818555      PMCID： PMC3974820          DOI： 10.1097/INF.0b013e3181862ae1

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  4 in total

Review 1.  Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment, and diagnosis.

Authors:  J K Griffiths
Journal:  Adv Parasitol       Date:  1998       Impact factor: 3.870

2.  Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial.

Authors:  Beatrice Amadi; Mwiya Mwiya; John Musuku; Angela Watuka; Sandie Sianongo; Ayman Ayoub; Paul Kelly
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

3.  Cryptosporidiosis among black children in hospital in South Africa.

Authors:  G M van den Ende
Journal:  J Infect       Date:  1986-07       Impact factor: 6.072

4.  High prevalence of Cryptosporidium in young children with prolonged diarrhea.

Authors:  P Jirapinyo; K Ruangsiri; S Tesjaroen; N Limsathayourat; J Sripiangjan; A Yoolek; V Junnoo
Journal:  Southeast Asian J Trop Med Public Health       Date:  1993-12       Impact factor: 0.267
  4 in total
  1 in total

1.  A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.

Authors:  Momar Ndao; Milli Nath-Chowdhury; Mohammed Sajid; Victoria Marcus; Susan T Mashiyama; Judy Sakanari; Eric Chow; Zachary Mackey; Kirkwood M Land; Matthew P Jacobson; Chakrapani Kalyanaraman; James H McKerrow; Michael J Arrowood; Conor R Caffrey
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.